Search research articles
Contact Us
Filters
Showing results (191-200 of 710) with videos related to
Page
of 71
Sort By:
Kidney International
|
February 19, 2002
Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production
Hiroyuki Kobori, Lisa M Harrison-Bernard, L Gabriel Navar
Hypertension (Dallas, Tex. : 1979)
|
February 4, 1999
Annual progress report: our 20th anniversary celebration
E D Frohlich, R N Ré, L G Navar
American Journal of Surgery
|
December 1, 1985
Effect of inhalation injury on fluid resuscitation requirements after thermal injury
P D Navar, J R Saffle, G D Warden
The New England Journal of Medicine
|
July 23, 2025
Lepodisiran - A Long-Duration Small Interfering RNA Targeting Lipoprotein(a). Reply
Steven E Nissen, Ann Marie Navar, John H Krege
Journal of Clinical and Translational Science
|
January 12, 2026
Comparing survey delivery methods in healthcare: A randomized study
Gayane Tumyan, Kathleen Esselink, Ann Marie Navar, et al.
Journal of the American Society of Nephrology : JASN
|
February 22, 2001
Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension
Hiroyuki Kobori, Lisa M Harrison-Bernard, L Gabriel Navar
The American Journal of Physiology
|
July 1, 1990
Prostaglandin influences on afferent arteriolar responses to vasoconstrictor agonists
E W Inscho, P K Carmines, L G Navar
Clinical Science (London, England : 1979)
|
June 1, 1982
Effects of saralasin infusion on bilateral renal function in two-kidney, one-clip Goldblatt hypertensive rats
W C Huang, D W Ploth, L G Navar
American Journal of Physiology. Renal Physiology
|
April 21, 2020
Purinergic P2X<sub>1</sub> receptor, purinergic P2X<sub>7</sub> receptor, and angiotensin II type 1 receptor interactions in the regulation of renal afferent arterioles in angiotensin II-dependent hypertension
Supaporn Kulthinee, Weijian Shao, Martha Franco, et al.
Diabetes Care
|
June 29, 2004
Real world effectiveness of rosiglitazone added to maximal (tolerated) doses of metformin and a sulfonylurea agent: a systematic evaluation of triple oral therapy in a minority population
Rajiv Roy, Maria Navar, Gladys Palomeno, et al.
Page
of 71
Search research articles
Search
Showing results (191-200 of 710) with videos related to
Sort By:
Page
of 71
Kidney International
|
February 19, 2002
Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production
Hiroyuki Kobori, Lisa M Harrison-Bernard, L Gabriel Navar
Hypertension (Dallas, Tex. : 1979)
|
February 4, 1999
Annual progress report: our 20th anniversary celebration
E D Frohlich, R N Ré, L G Navar
American Journal of Surgery
|
December 1, 1985
Effect of inhalation injury on fluid resuscitation requirements after thermal injury
P D Navar, J R Saffle, G D Warden
The New England Journal of Medicine
|
July 23, 2025
Lepodisiran - A Long-Duration Small Interfering RNA Targeting Lipoprotein(a). Reply
Steven E Nissen, Ann Marie Navar, John H Krege
Journal of Clinical and Translational Science
|
January 12, 2026
Comparing survey delivery methods in healthcare: A randomized study
Gayane Tumyan, Kathleen Esselink, Ann Marie Navar, et al.
Journal of the American Society of Nephrology : JASN
|
February 22, 2001
Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension
Hiroyuki Kobori, Lisa M Harrison-Bernard, L Gabriel Navar
The American Journal of Physiology
|
July 1, 1990
Prostaglandin influences on afferent arteriolar responses to vasoconstrictor agonists
E W Inscho, P K Carmines, L G Navar
Clinical Science (London, England : 1979)
|
June 1, 1982
Effects of saralasin infusion on bilateral renal function in two-kidney, one-clip Goldblatt hypertensive rats
W C Huang, D W Ploth, L G Navar
American Journal of Physiology. Renal Physiology
|
April 21, 2020
Purinergic P2X<sub>1</sub> receptor, purinergic P2X<sub>7</sub> receptor, and angiotensin II type 1 receptor interactions in the regulation of renal afferent arterioles in angiotensin II-dependent hypertension
Supaporn Kulthinee, Weijian Shao, Martha Franco, et al.
Diabetes Care
|
June 29, 2004
Real world effectiveness of rosiglitazone added to maximal (tolerated) doses of metformin and a sulfonylurea agent: a systematic evaluation of triple oral therapy in a minority population
Rajiv Roy, Maria Navar, Gladys Palomeno, et al.
Page
of 71